Zankel Todd 4
4 · Raptor Pharmaceutical Corp · Filed Sep 5, 2012
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-09-04$5.00/sh−842$4,210→ 651,866 total
Footnotes (1)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.